164 related articles for article (PubMed ID: 31228270)
1. Expression of estrogen receptor alpha is associated with pathogenesis and prognosis of human papillomavirus-positive oropharyngeal cancer.
Kano M; Kondo S; Wakisaka N; Wakae K; Aga M; Moriyama-Kita M; Ishikawa K; Ueno T; Nakanishi Y; Hatano M; Endo K; Sugimoto H; Kitamura K; Muramatsu M; Yoshizaki T
Int J Cancer; 2019 Sep; 145(6):1547-1557. PubMed ID: 31228270
[TBL] [Abstract][Full Text] [Related]
2. APOBEC3A associates with human papillomavirus genome integration in oropharyngeal cancers.
Kondo S; Wakae K; Wakisaka N; Nakanishi Y; Ishikawa K; Komori T; Moriyama-Kita M; Endo K; Murono S; Wang Z; Kitamura K; Nishiyama T; Yamaguchi K; Shigenobu S; Muramatsu M; Yoshizaki T
Oncogene; 2017 Mar; 36(12):1687-1697. PubMed ID: 27694899
[TBL] [Abstract][Full Text] [Related]
3. Double positivity for HPV-DNA/p16
Mena M; Taberna M; Tous S; Marquez S; Clavero O; Quiros B; Lloveras B; Alejo M; Leon X; Quer M; Bagué S; Mesia R; Nogués J; Gomà M; Aguila A; Bonfill T; Blazquez C; Guix M; Hijano R; Torres M; Holzinger D; Pawlita M; Pavon MA; Bravo IG; de Sanjosé S; Bosch FX; Alemany L
Oral Oncol; 2018 Mar; 78():137-144. PubMed ID: 29496041
[TBL] [Abstract][Full Text] [Related]
4. Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database.
Rettig EM; Zaidi M; Faraji F; Eisele DW; El Asmar M; Fung N; D'Souza G; Fakhry C
Oral Oncol; 2018 Aug; 83():147-153. PubMed ID: 30098771
[TBL] [Abstract][Full Text] [Related]
5. The IL-1/IL-1R axis induces greater fibroblast-derived chemokine release in human papillomavirus-negative compared to positive oropharyngeal cancer.
Al-Sahaf S; Hunter KD; Bolt R; Ottewell PD; Murdoch C
Int J Cancer; 2019 Jan; 144(2):334-344. PubMed ID: 30191960
[TBL] [Abstract][Full Text] [Related]
6. Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy.
Koenigs MB; Lefranc-Torres A; Bonilla-Velez J; Patel KB; Hayes DN; Glomski K; Busse PM; Chan AW; Clark JR; Deschler DG; Emerick KS; Hammon RJ; Wirth LJ; Lin DT; Mroz EA; Faquin WC; Rocco JW
J Natl Cancer Inst; 2019 Sep; 111(9):933-942. PubMed ID: 30715409
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
[TBL] [Abstract][Full Text] [Related]
8. Biologic and behavioral associations of estrogen receptor alpha positivity in head and neck squamous cell carcinoma.
Drake V; Bigelow E; Fakhry C; Windon M; Rooper LM; Ha P; Miles B; Gourin C; Mandal R; Mydlarz W; London N; Vosler PS; Yavvari S; Troy T; Waterboer T; Eisele DW; D'Souza G
Oral Oncol; 2021 Oct; 121():105461. PubMed ID: 34304004
[TBL] [Abstract][Full Text] [Related]
9. Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary.
Tanaka H; Suzuki M; Takemoto N; Fukusumi T; Eguchi H; Takai E; Kanai H; Tatsumi M; Horie M; Takenaka Y; Yachida S; Inohara H
Int J Cancer; 2022 Jan; 150(1):174-186. PubMed ID: 34486724
[TBL] [Abstract][Full Text] [Related]
10. HPV11 E6 mutation by overexpression of APOBEC3A and effects of interferon-ω on APOBEC3s and HPV11 E6 expression in HPV11.HaCaT cells.
Wang Y; Li X; Song S; Sun Y; Zhang J; Yu C; Chen W
Virol J; 2017 Nov; 14(1):211. PubMed ID: 29100527
[TBL] [Abstract][Full Text] [Related]
11. EGFR overexpression and macrophage infiltration correlate with poorer prognosis in HPV-negative oropharyngeal cancer via STAT6 signaling.
Lee HP; Li CJ; Lee CC
Head Neck; 2024 Jun; 46(6):1294-1303. PubMed ID: 38497289
[TBL] [Abstract][Full Text] [Related]
12. 'Good cancer gone bad': a narrative review of HPV oropharyngeal cancer and potential poor outcomes.
Alabi O; O'Neill JP
Eur Arch Otorhinolaryngol; 2020 Aug; 277(8):2185-2191. PubMed ID: 32333138
[TBL] [Abstract][Full Text] [Related]
13. Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.
Warren CJ; Westrich JA; Doorslaer KV; Pyeon D
Viruses; 2017 Aug; 9(8):. PubMed ID: 28825669
[TBL] [Abstract][Full Text] [Related]
14. Oropharyngeal cancer prognosis by tumour HPV status in France: The multicentric Papillophar study.
Lacau St Guily J; Rousseau A; Baujat B; Périé S; Schultz P; Barry B; Dufour X; Malard O; Pretet JL; Clavel C; Birembaut P; Franceschi S;
Oral Oncol; 2017 Apr; 67():29-36. PubMed ID: 28351578
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status.
Faraji F; Rettig EM; Tsai HL; El Asmar M; Fung N; Eisele DW; Fakhry C
Cancer; 2019 Mar; 125(5):761-769. PubMed ID: 30521092
[TBL] [Abstract][Full Text] [Related]
17. HPV-negative, but not HPV-positive, oropharyngeal carcinomas induce fibroblasts to support tumour invasion through micro-environmental release of HGF and IL-6.
Bolt R; Foran B; Murdoch C; Lambert DW; Thomas S; Hunter KD
Carcinogenesis; 2018 Feb; 39(2):170-179. PubMed ID: 29140428
[TBL] [Abstract][Full Text] [Related]
18. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of human papillomavirus detection in oral rinse as a biomarker of oropharyngeal cancer.
Yoshida H; Murono S; Ueno T; Nakanishi Y; Tsuji A; Hatano M; Endo K; Kondo S; Sugimoto H; Wakisaka N; Yoshizaki T
Acta Otolaryngol; 2017 Jul; 137(7):773-777. PubMed ID: 28093931
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of human papillomavirus in oropharyngeal cancer in a New Zealand population.
Lucas-Roxburgh R; Benschop J; Lockett B; van den Heever U; Williams R; Howe L
PLoS One; 2017; 12(10):e0186424. PubMed ID: 29049330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
